We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Critical Care

Mortality Trends in Mechanically Ventilated ARDS: 20 Years of Paradox Revealed

MedXY Editorial Team•Apr 2, 2026•Critical Care
ARDSICD Codingmechanical ventilationmortality trendsNational Inpatient Sample

Highlights

• A 20-year retrospective analysis of 205,393 mechanically ventilated ARDS admissions reveals mortality declined during the ICD-9 era (OR 0.96/year) but paradoxically increased during the ICD-10 period (OR 1.05/year).
• The ICD-10 cohort demonstrated greater comorbidity burden and higher prevalence of pulmonary ARDS etiology, potentially explaining the mortality reversal.
• Hospitalization costs and length of stay improved during ICD-9 but plateaued in the ICD-10 era, reflecting increasing complexity of surviving patients.
• These findings underscore the critical importance of accounting for coding transitions and patient case-mix when interpreting longitudinal ARDS outcomes.

Background: The Enduring Challenge of ARDS

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Mechanical Ventilation-Induced Neutrophil Extracellular Vesicles: A Novel Mediator in Postoperative Pulmonary ComplicationsMechanical ventilation during surgery induces neutrophil extracellular vesicles that propagate lung inflammation and contribute to postoperative pulmonary complications, highlighting potential new biomarkers and therapeutic targets.Sep 17, 2026Extracorporeal Membrane Oxygenation without Mechanical Ventilation in ARDS: Insights from an International Cohort StudyThis study evaluates ECMO as a standalone respiratory support in ARDS patients avoiding invasive mechanical ventilation, highlighting outcomes, strategy failures, and mortality implications.Sep 17, 2026Evaluating the Impact of Early Mobilization in Mechanically Ventilated ICU Patients with Sepsis or Acute Respiratory Failure: Insights from the EVER Multicenter RCTThe EVER trial examined if a structured early mobilization protocol improves functional outcomes in ventilated patients with sepsis or respiratory failure. Despite earlier and increased mobilization, no significant functional benefit was obSep 6, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Understanding Acute Hypoxemic Respiratory Failure in ICU Patients: Epidemiology, Ventilatory Management, and Outcomes from a Multi-ICU Cohort Study
This study reveals that acute hypoxemic respiratory failure (AHRF) affects half of ICU patients needing respiratory support, with severity linked to worse outcomes. Lung-protective ventilation is common, underscoring the need for standardiz
Sep 1, 2026
How Respiratory Mechanics Shapes Ventilator Settings and Outcomes in Acute Brain Injury PatientsThis study reveals how respiratory system elastance influences the effects of tidal volume and respiratory rate on outcomes in mechanically ventilated acute brain injury patients, suggesting personalized ventilation strategies based on respAug 25, 2026
Interleukin-6 as a Central Mediator of Therapeutic Success in Acute Lung Injury and COVID-19This article examines interleukin-6 (IL-6) as a key mediator of therapeutic efficacy in acute lung injury and COVID-19, highlighting its role in modulating inflammation and survival outcomes across multiple clinical interventions.Aug 6, 2026